Application | Comment | Organism |
---|---|---|
medicine | fatty acid amide hydrolase is a promising target for the development of drugs to treat neurological diseases | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(4-cyclohexylphenoxy)-N-[2-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-(4-cyclohexylphenoxy)-N-[3-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-(4-cyclohexylphenoxy)-N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-(4-cyclohexylphenoxy)-N-[4-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-(4-cyclohexylphenoxy)-N-[4-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-[([1,1'-biphenyl]-4-yl)oxy]-N-[2-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-[([1,1'-biphenyl]-4-yl)oxy]-N-[3-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-[([1,1'-biphenyl]-4-yl)oxy]-N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-[([1,1'-biphenyl]-4-yl)oxy]-N-[4-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-[[(2E)-hex-2-en-1-yl]oxy]-N-[2-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-[[(2E)-hex-2-en-1-yl]oxy]-N-[3-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-[[(2E)-hex-2-en-1-yl]oxy]-N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
2-[[(2E)-hex-2-en-1-yl]oxy]-N-[4-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | - |
Rattus norvegicus | |
N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]-2-phenoxyacetamide | - |
Rattus norvegicus | |
N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]-2-[4-(propan-2-yl)phenoxy]acetamide | - |
Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | P97612 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-arachidonoylethanolamine + H2O | - |
Rattus norvegicus | arachidonic acid + ethanolamine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
FAAH | - |
Rattus norvegicus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00035 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-(4-cyclohexylphenoxy)-N-[4-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.00062 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-[([1,1'-biphenyl]-4-yl)oxy]-N-[4-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.00063 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-[([1,1'-biphenyl]-4-yl)oxy]-N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.00065 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-(4-cyclohexylphenoxy)-N-[2-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.0011 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-[([1,1'-biphenyl]-4-yl)oxy]-N-[2-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.0015 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-(4-cyclohexylphenoxy)-N-[4-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.0021 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]-2-[4-(propan-2-yl)phenoxy]acetamide | |
0.0026 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-(4-cyclohexylphenoxy)-N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.0055 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-[[(2E)-hex-2-en-1-yl]oxy]-N-[2-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.013 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-[([1,1'-biphenyl]-4-yl)oxy]-N-[3-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.017 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-[[(2E)-hex-2-en-1-yl]oxy]-N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.018 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]-2-phenoxyacetamide | |
0.047 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-(4-cyclohexylphenoxy)-N-[3-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.064 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-[[(2E)-hex-2-en-1-yl]oxy]-N-[4-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide | |
0.073 | - |
assay in brain homogenates, substrate ananamide, pH and temperature not specified in the publication | Rattus norvegicus | 2-[[(2E)-hex-2-en-1-yl]oxy]-N-[3-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl]acetamide |